Q-PAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Q-pam, and when can generic versions of Q-pam launch?
Q-pam is a drug marketed by Quantum Pharmics and is included in six NDAs.
The generic ingredient in Q-PAM is diazepam. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Q-pam
A generic version of Q-PAM was approved as diazepam by MYLAN on September 4th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for Q-PAM?
- What are the global sales for Q-PAM?
- What is Average Wholesale Price for Q-PAM?
Summary for Q-PAM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Patent Applications: | 4,162 |
DailyMed Link: | Q-PAM at DailyMed |
US Patents and Regulatory Information for Q-PAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 070423-001 | Dec 12, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 072432-001 | Apr 29, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 072431-001 | Apr 29, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 070424-001 | Dec 12, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 072433-001 | Apr 29, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | Q-PAM | diazepam | TABLET;ORAL | 070425-001 | Dec 12, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |